Skip to main content
Have a personal or library account? Click to login
WHF Position Statement on COVID Vaccination Cover

WHF Position Statement on COVID Vaccination

Open Access
|Apr 2021

References

  1. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int.
  2. V’Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat Rev Microbiol. 2021; 19: 155170. DOI: 10.1038/s41579-020-00468-6
  3. Wang N, Shang J, Jiang S, Du L. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses. Front Microbiol. 2020; 11: 298. DOI: 10.3389/fmicb.2020.00298
  4. Mohan T, Verma P, Rao DN. Novel adjuvants & delivery vehicles for vaccines development: A road ahead. Indian J Med Res. 2013; 138: 779795.
  5. Forni G, Mantovani A, Covid-19 Commission of Accademia Nazionale dei Lincei R. COVID-19 vaccines: Where we stand and challenges ahead. Cell Death Differ. 2021. DOI: 10.1038/s41418-020-00720-9
  6. Times. TNY. Covid-19 Vaccine Tracker Updates: The Latest nytimescom 2021; Sect. nytimes.com.
  7. https://wwwlinceiit/sites/default/files/documenti/Commissioni/ANL_Comm_Covid-19_Vaccines_1november2020pdf.
  8. Liu MA. Immunologic basis of vaccine vectors. Immunity. 2010; 33: 504515. DOI: 10.1016/j.immuni.2010.10.004
  9. CDC Report. Emerging SARS-CoV-2 Variants https://wwwcdcgov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variantshtml.
  10. Tang JW, Toovey OTR, Harvey KN, Hui DDS. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK. J Infect. 2021. DOI: 10.1016/j.jinf.2021.01.007
  11. Iwata-Yoshikawa N, Uda A, Suzuki T, et al. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol. 2014; 88: 85978614. DOI: 10.1128/JVI.00983-14
  12. Baden LR, El Sahly HM, Essink B, et al.Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. The New England journal of medicine. 2021; 384: 403416. DOI: 10.1056/NEJMoa2035389
  13. Walsh EE, Frenck RW, Jr., Falsey AR, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England journal of medicine. 2020; 383: 24392450. DOI: 10.1056/NEJMoa2027906
  14. Perricone C, Triggianese P, Bartoloni E, et al.The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020; 111: 102468. DOI: 10.1016/j.jaut.2020.102468
  15. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020; 141: 16481655. DOI: 10.1161/CIRCULATIONAHA.120.046941
  16. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. Journal of the American College of Cardiology. 2020; 75: 23522371. DOI: 10.1016/j.jacc.2020.03.031
  17. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA cardiology. 2020; 5: 831840. DOI: 10.1001/jamacardio.2020.1286
  18. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA internal medicine. 2020; 180: 934943. DOI: 10.1001/jamainternmed.2020.0994
  19. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine. 2020; 382: 11991207. DOI: 10.1056/NEJMoa2001316
  20. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395: 10541062. DOI: 10.1016/S0140-6736(20)30566-3
  21. Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. Journal of the American College of Cardiology. 2017; 70: 125. DOI: 10.1016/j.jacc.2017.04.052
  22. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020; 7: 11. DOI: 10.1186/s40779-020-00240-0
  23. Bohm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: Expert document from the German Cardiac Society and the World Heart Federation. Clinical research in cardiology: Official journal of the German Cardiac Society. 2020; 109: 14461459. DOI: 10.1007/s00392-020-01656-3
  24. Haga S, Yamamoto N, Nakai-Murakami C, et al. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci U S A. 2008; 105: 78097814. DOI: 10.1073/pnas.0711241105
  25. Grover SP, Mackman N. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis. Arterioscler Thromb Vasc Biol. 2018; 38: 709725. DOI: 10.1161/ATVBAHA.117.309846
  26. Glowacka I, Bertram S, Herzog P, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 2010; 84: 11981205. DOI: 10.1128/JVI.01248-09
  27. Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020; 126: 14561474. DOI: 10.1161/CIRCRESAHA.120.317015
  28. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet. Respiratory medicine. 2020; 8: 475481. DOI: 10.1016/S2213-2600(20)30079-5
  29. Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection. 2020; 48: 773777. DOI: 10.1007/s15010-020-01424-5
  30. Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat Rev Endocrinol. 2021; 17: 1130. DOI: 10.1038/s41574-020-00435-4
  31. Radder RS, Quinn AE, Georges A, Sarre SD, Shine R. Genetic evidence for co-occurrence of chromosomal and thermal sex-determining systems in a lizard. Biol Lett. 2008; 4: 176178. DOI: 10.1098/rsbl.2007.0583
  32. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. The New England journal of medicine. 2013; 368: 20042013. DOI: 10.1056/NEJMra1216063
  33. Chakafana G, Mutithu D, Hoevelmann J, Ntusi N, Sliwa K. Interplay of COVID-19 and cardiovascular diseases in Africa: An observational snapshot. Clinical research in cardiology: Official journal of the German Cardiac Society. 2020; 109: 14601468. DOI: 10.1007/s00392-020-01720-y
  34. Magadum A, Kishore R. Cardiovascular Manifestations of COVID-19 Infection. Cells. 2020; 9; 2508. DOI: 10.3390/cells9112508
  35. Armstrong SM, Wang C, Tigdi J, et al. Influenza infects lung microvascular endothelium leading to microvascular leak: Role of apoptosis and claudin-5. PloS one. 2012; 7: e47323. DOI: 10.1371/journal.pone.0047323
  36. Pothineni NVK, Subramany S, Kuriakose K, et al. Infections, atherosclerosis, and coronary heart disease. European heart journal. 2017; 38: 31953201. DOI: 10.1093/eurheartj/ehx362
  37. Grossman E. Does increased oxidative stress cause hypertension? Diabetes Care. 2008; 31(Suppl 2): S185189. DOI: 10.2337/dc08-s246
  38. World Health Organization. Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca. https://wwwwhoint/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222–20211.
  39. COVAX Explained. https://wwwgaviorg/vaccineswork/covax-explained
  40. Mallapaty S. Vaccines are curbing COVID: Data from Israel show drop in infections. Nature. 2021; 590: 197. DOI: 10.1038/d41586-021-00316-4.
  41. Petter E, Mor O, Zuckerman N, et al. Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2. 2021. https://githubcom/ellapetter/COVID19/blob/main/Initial%20real%20world%20evidence%20for%20lower%20transmissibility%20of%20individuals%20who%20have%20been%20vaccinated%20by%20BNT162b2pdf.
  42. https://www.change.org/p/sa-department-of-health-we-need-a-vaccine-plan-now?recruiter=24520734&utm_source=share_petition&utm_medium=email&utm_campaign=share_email_responsive&recruited_by_id=e0e0a55d-b531-4ede-9d6d-67ff8cdc0a66; https://petition.parliament.uk/petitions/562854.
  43. CDC Covid Data Tracker. 2021. https://covid.cdc.gov/covid-data-tracker/#health-care-personnel.
  44. Rampini SK, Wolfensberger A, Sax H, Thienemann F. Preventing intrahospital transmission of COVID-19: Experience from the University Hospital Zurich in Switzerland. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2020; 110: 709710.
DOI: https://doi.org/10.5334/gh.1027 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 8, 2021
Accepted on: Mar 29, 2021
Published on: Apr 27, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 F. Thienemann, G. Chakafana, D. Piñeiro, F. J. Pinto, P. Perel, K. Singh, J.-L. Eiselé, D. Prabhakaran, K. Sliwa, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.